CRH and major depressive disorder: A diminished GABAergic input to the hypothalamic paraventricular nucleus may contribute to the activation of corticotropin releasing hormone-immunoreactivity neurons in depression, most prominently in major depression, which provides a rationale for prescribing GABAergic agonists for these patients (40).